Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.

CONCLUSIONS: Upstaging to pT3a in patients with cT1 renal mass undergoing RAPN represents an uncommon event, involving less than 5% of cases. Pathologic upstaging might translate into worse oncological outcomes, and therefore strict follow-up protocols should be applied in these cases. PMID: 31956077 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31956077?dopt=Abstract

Source: Urologic Oncology - January 15, 2020 Category: Urology & Nephrology Authors: Veccia A, Antonelli A, Minervini A, Mottrie A, Dell'Oglio P, Ashrafi AN, Larcher A, Eun D, Bradshaw A, Amparore D, Brassetti A, Hampton LJ, Simeone C, Mari A, Carini M, De Naeyer G, Yang K, Capitanio U, Simone G, Porpiglia F, Derweesh I, Aron M, Autorino Tags: Urol Oncol Source Type: research